The Hypothalamic Orexinergic System: Pain and Primary Headaches

The primary headaches are a group of distinct individually characterized attack forms, which although varying in presentation, share some common anatomical basis responsible for the pain component of the attack. The hypothalamus is known to modulate a multitude of functions and has been shown to be involved in the pathophysiology of a variety of primary headaches including cluster headache and chronic migraine. It seems likely that it may be involved in other primary headache disorders due to their episodic nature and may underlie many of their diverse symptoms. We discuss the hypothalamic involvement in the modulation of trigeminovascular processing and examine the involvement of the hypothalamic orexinergic system as a key regulator of this function.

[1]  J. Olesen The International Classification of Headache Disorders , 2008, Headache.

[2]  F. Chollet,et al.  Hypothalamic Activation in Spontaneous Migraine Attacks , 2007, Headache.

[3]  J. V. Gerven,et al.  Promotion of sleep by targeting the orexin system in rats, dogs and humans , 2007, Nature Medicine.

[4]  P. Goadsby,et al.  Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat , 2006, The European journal of neuroscience.

[5]  Gerardo Rojas-Piloni,et al.  Oxytocin and electrical stimulation of the paraventricular hypothalamic nucleus produce antinociceptive effects that are reversed by an oxytocin antagonist , 2006, PAIN.

[6]  Richard S. J. Frackowiak,et al.  Posterior hypothalamic activation in paroxysmal hemicrania , 2006, Annals of neurology.

[7]  T. Yaksh Central pharmacology of nociceptive transmission , 2006 .

[8]  P. Goadsby,et al.  Orexin 1 Receptor Activation Attenuates Neurogenic Dural Vasodilation in an Animal Model of Trigeminovascular Nociception , 2005, Journal of Pharmacology and Experimental Therapeutics.

[9]  T. Bartsch,et al.  Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus , 2005, Pain.

[10]  A. Ferguson,et al.  Non-sleep effects of hypocretin/orexin. , 2005, Sleep medicine reviews.

[11]  T. Sakurai Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. , 2005, Sleep medicine reviews.

[12]  P. Goadsby,et al.  Trigeminal autonomic cephalalgias. Pathophysiology and classification. , 2005, Revue neurologique.

[13]  Richard R. Neubig,et al.  International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.

[14]  A. Deutch,et al.  Dopaminergic regulation of orexin neurons , 2005, The European journal of neuroscience.

[15]  O. Yuge,,et al.  Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats , 2005, Brain Research.

[16]  Kazuhiro Takahashi,et al.  Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice , 2005, Peptides.

[17]  T. Sakurai Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology , 2005, Regulatory Peptides.

[18]  P. Goadsby,et al.  Trigeminal autonomic cephalalgias: fancy term or constructive change to the IHS classification? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  M. Yanagisawa,et al.  Persistent pain and stress activate pain-inhibitory orexin pathways , 2005, Neuroreport.

[20]  Karl J. Friston,et al.  A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. , 2004, Brain : a journal of neurology.

[21]  Matharu,et al.  Erratum: Subcutaneous octreotide in cluster headache: Randomized placebo-controlled double-blind crossover study (Annals of Neurology (October 2004) 56 (488-494)) , 2004 .

[22]  L. Pinessi,et al.  A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache , 2004, Neurology.

[23]  Satchidananda Panda,et al.  It’s All in the Timing: Many Clocks, Many Outputs , 2004, Journal of biological rhythms.

[24]  L. Kelman The Premonitory Symptoms (Prodrome): A Tertiary Care Study of 893 Migraineurs , 2004, Headache.

[25]  P. Goadsby,et al.  Subcutaneous octreotide in cluster headache: Randomized placebo‐controlled double‐blind crossover study , 2004, Annals of neurology.

[26]  Weontae Lee,et al.  Solution structure of human orexin-A: regulator of appetite and wakefulness. , 2004, Journal of biochemistry and molecular biology.

[27]  P. Erhard,et al.  Hypothalamic Activation in Trigeminal Autonomic Cephalgia: Functional Imaging of an Atypical Case , 2004, Cephalalgia : an international journal of headache.

[28]  H. Kaube,et al.  Glyceryl trinitrate triggers premonitory symptoms in migraineurs , 2004, Pain.

[29]  P. Goadsby,et al.  Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study , 2004, Neurobiology of Disease.

[30]  C. Leonard,et al.  Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum. , 2004, Journal of neurophysiology.

[31]  T. Bartsch,et al.  Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area , 2004, Pain.

[32]  H. Haas,et al.  Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons , 2004, The European journal of neuroscience.

[33]  R. Lipton,et al.  The epidemiology and impact of migraine , 2004, Current neurology and neuroscience reports.

[34]  O. Yuge,,et al.  Analgesic effect of intrathecal administration of orexin on neuropathic pain in rats. , 2004, In vivo.

[35]  A. May,et al.  Specific hypothalamic activation during a spontaneous cluster headache attack , 2004, Neurology.

[36]  J. Siegel Hypocretin (orexin): role in normal behavior and neuropathology. , 2004, Annual review of psychology.

[37]  F. Morales,et al.  Distribution of hypocretin (orexin) immunoreactivity in the feline pons and medulla , 2004, Brain Research.

[38]  S. Datta Cellular Basis of Pontine Ponto-geniculo-occipital Wave Generation and Modulation , 2004, Cellular and Molecular Neurobiology.

[39]  Jes Olesen,et al.  The International Classification of Headache Disorders: 2nd edition. , 2004, Cephalalgia : an international journal of headache.

[40]  L. Hwang,et al.  Antiallodynic Effects of Intrathecal Orexins in a Rat Model of Postoperative Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.

[41]  O. Saito,et al.  Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test. , 2003, European journal of pharmacology.

[42]  T. Chiba,et al.  Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model , 2003, Neuroscience Letters.

[43]  A. Ferguson,et al.  The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function , 2003, Frontiers in Neuroendocrinology.

[44]  G. Broggi,et al.  Hypothalamic deep brain stimulation for intractable chronic cluster headache: a 3-year follow-up , 2003, Neurological Sciences.

[45]  D. Liebeskind,et al.  Faces of the giant panda and her cub: MRI correlates of Wilson’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[46]  J. Parish,et al.  Clinical, Anatomical, and Physiologic Relationship Between Sleep and Headache , 2003, Headache.

[47]  N. Dahmen,et al.  Increased Frequency of Migraine in Narcoleptic Patients: A Confirmatory Study , 2003, Cephalalgia : an international journal of headache.

[48]  E. MacGregor,et al.  Migraine Prevalence and Treatment Patterns: The Global Migraine and Zolmitriptan Evaluation Survey , 2003, Headache.

[49]  Alec J Davidson,et al.  SCN: ringmaster of the circadian circus or conductor of the circadian orchestra? , 2003, Novartis Foundation symposium.

[50]  P. Ferroli,et al.  STIMULATION OF THE POSTERIOR HYPOTHALAMUS FOR TREATMENT OF CHRONIC INTRACTABLE CLUSTER HEADACHES : FIRST REPORTED SERIES , 2003 .

[51]  Sebastiaan Overeem,et al.  The hypothalamus in episodic brain disorders , 2002, The Lancet Neurology.

[52]  A. N. van den Pol,et al.  Hypocretins (Orexins) Regulate Serotonin Neurons in the Dorsal Raphe Nucleus by Excitatory Direct and Inhibitory Indirect Actions , 2002, The Journal of Neuroscience.

[53]  H. Haas,et al.  Convergent Excitation of Dorsal Raphe Serotonin Neurons by Multiple Arousal Systems (Orexin/Hypocretin, Histamine and Noradrenaline) , 2002, The Journal of Neuroscience.

[54]  T. Chiba,et al.  Analgesic effect of intrathecally administered orexin‐A in the rat formalin test and in the rat hot plate test , 2002, British journal of pharmacology.

[55]  O. Jöhren,et al.  Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus , 2002, Peptides.

[56]  A. Yamatodani,et al.  The effect of orexin-A and -B on the histamine release in the anterior hypothalamus in rats , 2002, Neuroscience Letters.

[57]  G. Hervieu,et al.  Protein distribution of the orexin-2 receptor in the rat central nervous system , 2002, Regulatory Peptides.

[58]  H. Haas,et al.  Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro , 2002, Regulatory Peptides.

[59]  T. Pringsheim Cluster Headache: Evidence for a Disorder of Circadian Rhythm and Hypothalamic Function , 2002, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[60]  R. Lipton,et al.  Migraine--current understanding and treatment. , 2002, The New England journal of medicine.

[61]  G. Hervieu,et al.  Orexin receptor‐1 (OX‐R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake , 2002, The European journal of neuroscience.

[62]  T. Kudo,et al.  Orexin A and B evoke noradrenaline release from rat cerebrocortical slices , 2001, British journal of pharmacology.

[63]  J L Go,et al.  The trigeminal nerve. , 2001, Seminars in ultrasound, CT, and MR.

[64]  S. Silberstein,et al.  Hypothalamic involvement in chronic migraine , 2001, Journal of neurology, neurosurgery, and psychiatry.

[65]  A Franzini,et al.  Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. , 2001, The New England journal of medicine.

[66]  M. Behbehani,et al.  Physiological characteristics of the projection pathway from the medial preoptic to the nucleus raphe magnus of the rat and its modulation by the periaqueductal gray , 2001, PAIN.

[67]  J. Holden,et al.  Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by α1- and α2-adrenoceptors , 2001, Brain Research.

[68]  C. Saper,et al.  A neurohistochemical blueprint for pain-induced loss of appetite , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[69]  K. Milenov,et al.  Antinociceptive effect of somatostatin microinjected into caudate putamen , 2001, Peptides.

[70]  C. Saper,et al.  Differential expression of orexin receptors 1 and 2 in the rat brain , 2001, The Journal of comparative neurology.

[71]  A. A. Parsons,et al.  Orexin-A, an hypothalamic peptide with analgesic properties , 2001, Pain.

[72]  J. Roberts,et al.  Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord , 2001, Neuroscience.

[73]  R. Porter,et al.  Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor. , 2001, Bioorganic & medicinal chemistry letters.

[74]  H. Haas,et al.  Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat , 2001, Neuropharmacology.

[75]  T. Okumura,et al.  Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation. , 2001, Biochemical and biophysical research communications.

[76]  O. Jöhren,et al.  Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. , 2001, Endocrinology.

[77]  J. Holden,et al.  Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by alpha(1)- and alpha(2)-adrenoceptors. , 2001, Brain research.

[78]  C. Small,et al.  Central Administration of Orexin A Suppresses Basal and Domperidone Stimulated Plasma Prolactin , 2000, Journal of neuroendocrinology.

[79]  R S Frackowiak,et al.  PET and MRA findings in cluster headache and MRA in experimental pain , 2000, Neurology.

[80]  M. Parmentier,et al.  The Orexin OX1 Receptor Activates a Novel Ca2+ Influx Pathway Necessary for Coupling to Phospholipase C* , 2000, The Journal of Biological Chemistry.

[81]  Sebastiaan Overeem,et al.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains , 2000, Nature Medicine.

[82]  A. Beck‐Sickinger,et al.  On the synthesis of orexin A: a novel one‐step procedure to obtain peptides with two intramolecular disulphide bonds , 2000, Journal of peptide science : an official publication of the European Peptide Society.

[83]  M. Nakazato,et al.  Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord , 2000, Neuroscience Letters.

[84]  A. Macgregor Migraine associated with menstruation. , 2000, Functional neurology.

[85]  C. V. van Eden,et al.  The integration of stress by the hypothalamus, amygdala and prefrontal cortex: balance between the autonomic nervous system and the neuroendocrine system. , 2000, Progress in brain research.

[86]  E. Bang,et al.  Solution structure of a new hypothalamic neuropeptide, human hypocretin-2/orexin-B. , 1999, European journal of biochemistry.

[87]  G. Aston-Jones,et al.  Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system , 1999, The Journal of comparative neurology.

[88]  Shelagh Wilson,et al.  Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord☆ , 1999, Peptides.

[89]  T. Horvath,et al.  Brain Uncoupling Protein 2: Uncoupled Neuronal Mitochondria Predict Thermal Synapses in Homeostatic Centers , 1999, The Journal of Neuroscience.

[90]  C. Büchel,et al.  Functional magnetic resonance imaging in spontaneous attacks of SUNCT: Short‐lasting neuralgiform headache with conjunctival injection and tearing , 1999, Annals of neurology.

[91]  D. Smart Orexins: a new family of neuropeptides. , 1999, British journal of anaesthesia.

[92]  T. Sakurai,et al.  Structure, tissue distribution, and pharmacological characterization of Xenopus orexins , 1999, Peptides.

[93]  T. A. Harrison,et al.  Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla , 1999, Neuroscience Letters.

[94]  M. Nakazato,et al.  Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models , 1999, Neuroscience Letters.

[95]  D. Middlemiss,et al.  Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell‐line using FLIPR , 1999, British journal of pharmacology.

[96]  M. T. Shipley,et al.  The organization of preoptic–medullary circuits in the male rat: evidence for interconnectivity of neural structures involved in reproductive behavior, antinociception and cardiovascular regulation , 1999, Neuroscience.

[97]  Karl J. Friston,et al.  Correlation between structural and functional changes in brain in an idiopathic headache syndrome , 1999, Nature Medicine.

[98]  H. Romijn,et al.  Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway , 1999, The European journal of neuroscience.

[99]  A. Pol Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord , 1999 .

[100]  J. Carroll,et al.  Cloning of porcine prepro-orexin cDNA and effects of an intramuscular injection of synthetic porcine orexin-B on feed intake in young pigs. , 1999, Domestic animal endocrinology.

[101]  N. Dahmen,et al.  Increased frequency of migraine in narcoleptic patients , 1999, Neurology.

[102]  M. Yanagisawa,et al.  Widespread distribution of orexin in rat brain and its regulation upon fasting. , 1999, Biochemical and biophysical research communications.

[103]  S. Schulz,et al.  Selective targeting of somatostatin receptor 3 to neuronal cilia , 1999, Neuroscience.

[104]  S. L. Dun,et al.  Orexin A-like immunoreactivity in the rat brain , 1999, Neuroscience Letters.

[105]  A. N. van den Pol,et al.  Synaptic Interaction between Hypocretin (Orexin) and Neuropeptide Y Cells in the Rodent and Primate Hypothalamus: A Novel Circuit Implicated in Metabolic and Endocrine Regulations , 1999, The Journal of Neuroscience.

[106]  M. Millan,et al.  The induction of pain: an integrative review , 1999, Progress in Neurobiology.

[107]  T. Sakurai,et al.  Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[108]  A. N. van den Pol,et al.  Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.

[109]  D. Macneil,et al.  Distribution of orexin receptor mRNA in the rat brain , 1998, FEBS letters.

[110]  A. N. van den Pol,et al.  Presynaptic and Postsynaptic Actions and Modulation of Neuroendocrine Neurons by a New Hypothalamic Peptide, Hypocretin/Orexin , 1998, The Journal of Neuroscience.

[111]  Christian Büchel,et al.  Hypothalamic activation in cluster headache attacks , 1998, The Lancet.

[112]  P. Emson,et al.  Identification of somatostatin sst2(a) receptor expressing neurones in central regions involved in nociception , 1998, Brain Research.

[113]  A. Fox,et al.  Migraine Chronobiology , 1998, Headache.

[114]  K. Franklin,et al.  Morphine analgesia in the formalin test: reversal by microinjection of quaternary naloxone into the posterior hypothalamic area or periaqueductal gray , 1998, Behavioural Brain Research.

[115]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[116]  F E Bloom,et al.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[117]  S. Carr,et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.

[118]  N. Zurak Role of the Suprachiasmatic Nucleus in the Pathogenesis of Migraine Attacks , 1997, Cephalalgia : an international journal of headache.

[119]  B. Lumb,et al.  Inhibitory effects evoked from the anterior hypothalamus are selective for the nociceptive responses of dorsal horn neurons with high- and low-threshold inputs. , 1997, Journal of neurophysiology.

[120]  D. Bereiter Morphine and somatostatin analogue reduce c-fos expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat , 1997, Neuroscience.

[121]  E. Ovalı,et al.  Treatment of Migraine Attacks with A Long-Acting Somatostatin Analogue (Octreotide, SMS 201-995) , 1997, Cephalalgia : an international journal of headache.

[122]  R. Lipton,et al.  A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. , 1997, Brain : a journal of neurology.

[123]  P. Emson,et al.  Somatostatin receptors in the central nervous system , 1996, Progress in Neurobiology.

[124]  J. Giesler Evidence of direct nociceptive projections from the spinal cord to the hypothalamus and telencephalon , 1995 .

[125]  J. Stamford Descending control of pain. , 1995, British journal of anaesthesia.

[126]  C. Weiller,et al.  Brain stem activation in spontaneous human migraine attacks , 1995, Nature Medicine.

[127]  J. Sandkühler,et al.  Inhibition of spinal nociceptive neurons by microinjections of somatostatin into the nucleus raphe magnus and the midbrain periaqueductal gray of the anesthetized cat , 1995, Neuroscience Letters.

[128]  A. Beaudet,et al.  Patterns of expression of SSTR1 and SSTR2 somatostatin receptor subtypes in the hypothalamus of the adult rat: relationship to neuroendocrine function , 1995, Neuroscience.

[129]  W. Stewart,et al.  Population variation in migraine prevalence: a meta-analysis. , 1995, Journal of clinical epidemiology.

[130]  Y. Olsson,et al.  Intrathecal and Epidural Somatostatin for Patients with Cancer: Analgesic Effects and Postmortem Neuropathologic Investigations of Spinal Cord and Nerve Roots , 1994, Anesthesiology.

[131]  M. Quartu,et al.  Somatostatin, galanin and peptide histidine isoleucine in the newborn and adult human trigeminal ganglion and spinal nucleus: Immunohistochemistry, neuronal morphometry and colocalization with substance P , 1994, Journal of Chemical Neuroanatomy.

[132]  D. Hoyer,et al.  Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. , 1994, Digestion.

[133]  H. Göbel,et al.  [Migraine and tension headache. New procedures for objective differentiation]. , 1992, Fortschritte der Medizin.

[134]  A. Dickenson,et al.  The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn of the rat spinal cord , 1992, Neuropeptides.

[135]  J. Olesen,et al.  Migraine With Aura and Migraine Without Aura: An Epidemiological Study , 1992, Cephalalgia : an international journal of headache.

[136]  G. Solomon,et al.  Circadian rhythms and migraine. , 1992, Cleveland Clinic journal of medicine.

[137]  N. Breslau,et al.  Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults , 1991, Psychiatry Research.

[138]  J. Olesen,et al.  Epidemiology of headache in a general population--a prevalence study. , 1991, Journal of clinical epidemiology.

[139]  B. Lumb Hypothalamic influences on viscero‐somatic neurones in the lower thoracic spinal cord of the anaesthetized rat. , 1990, The Journal of physiology.

[140]  N. Lazarov,et al.  Localization of somatostatin-like immunoreactive fibres in the trigeminal principal sensory nucleus of the cat. , 1990, Acta histochemica.

[141]  E. Carstens,et al.  Medial hypothalamic stimulation suppresses nociceptive spinal dorsal horn neurons but not the tail-flick reflex in the rat , 1988, Brain Research.

[142]  N. Raskin,et al.  Headache May Arise From Perturbation of Brain , 1987, Headache.

[143]  E. Carstens Hypothalamic inhibition of rat dorsal horn neuronal responses to noxious skin heating , 1986, Pain.

[144]  J. Chrubasik,et al.  The Effect of Epidural Somatostatin on Postoperative Pain , 1985, Anesthesia and analgesia.

[145]  M. Moskowitz The neurobiology of vascular head pain , 1984, Annals of neurology.

[146]  R. Przewłocki,et al.  Evidence for a role of the ventro-medial posterior hypothalamus in nociceptive processes in the rat , 1983, Pharmacology Biochemistry and Behavior.

[147]  Moore Ry Organization and function of a central nervous system circadian oscillator: the suprachiasmatic hypothalamic nucleus. , 1983 .

[148]  E. Carstens,et al.  Inhibition of spinal dorsal horn neuronal responses to noxious skin heating by lateral hypothalamic stimulation in the cat. , 1983, Journal of neurophysiology.

[149]  R. Moore Organization and function of a central nervous system circadian oscillator: the suprachiasmatic hypothalamic nucleus. , 1983, Federation proceedings.

[150]  E. Carstens,et al.  Inhibition of spinal dorsal horn neuronal responses to noxious skin heating by medial hypothalamic stimulation in the cat. , 1982, Journal of neurophysiology.

[151]  M. Randić,et al.  The actions of neuropeptides on dorsal horn neurons in the rat spinal cord slice preparation: an intracellular study , 1982, Brain Research.

[152]  H. J. Gamble The Human Nervous System. An Anatomical Viewpoint , 1980 .

[153]  M. Randić,et al.  Depressant actions of methionine-enkephalin and somatostatin in cat dorsal horn neurones activated by noxious stimuli , 1978, Brain Research.

[154]  W. R. Ingram THE HYPOTHALAMUS , 1938, Ciba clinical symposia.

[155]  J. Turner ANATOMY OF THE CENTRAL NERVOUS SYSTEM , 1955 .

[156]  H. Wolff,et al.  EXPERIMENTAL STUDIES ON HEADACHE , 1942 .

[157]  H. Wolff,et al.  EXPERIMENTAL STUDIES ON HEADACHE: PAIN-SENSITIVE STRUCTURES OF THE HEAD AND THEIR SIGNIFICANCE IN HEADACHE , 1940 .